Mirati Therapeutics, Inc. (MRTX) Stock Analysis
DELISTED 2024
What happened to Mirati Therapeutics, Inc. (MRTX) stock?
Mirati Therapeutics, Inc. (MRTX) no longer trades on public markets. It was delisted in January 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2024
- Last recorded price (historical):
- $58.70 (last quote on record before the January 2024 delisting; historical, not a current quote)
Market cap $4.12B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Mirati Therapeutics, Inc. (MRTX). Mirati Therapeutics, Inc. is a clinical-stage oncology company focused on developing therapies for genetic and immunological drivers of cancer.
Last analyzed: May 10, 2026Mirati Therapeutics, Inc. (MRTX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy MRTX shares?
No. MRTX stopped trading on public markets in January 2024, so the shares are not available through a broker. Anything you see quoted for MRTX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before MRTX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Mirati Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.